D. Carr

First name
D.
Middle name
F.
Last name
Carr
Carr, D. F., O\textquoterightMeara, H., Jorgensen, A. L., Campbell, J., Hobbs, M., McCann, G., et al. (2013). SLCO1B1 genetic variant associated with statin-induced myopathy: a proof-of-concept study using the clinical practice research datalink. Clin Pharmacol Ther. http://doi.org/10.1038/clpt.2013.161
van Staa, T. P., Carr, D. F., O\textquoterightMeara, H., McCann, G., & Pirmohamed, M. (2014). Predictors and outcomes of increases in creatine phosphokinase concentrations or rhabdomyolysis risk during statin treatment. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.12367
O\textquoterightMeara, H., Carr, D. F., Evely, J., Hobbs, M., McCann, G., Van Staa, T., & Pirmohamed, M. (2014). Electronic health records for biological sample collection: feasibility study of statin-induced myopathy using the Clinical Practice Research Datalink. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.12269
Floyd, J. S., Bloch, K. M., Brody, J. A., Maroteau, C., Siddiqui, M. K., Gregory, R., et al. (2019). Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencing. PLoS One. http://doi.org/10.1371/journal.pone.0218115
Carr, D. F., Francis, B., Jorgensen, A. L., Zhang, E., Chinoy, H., Heckbert, S. R., et al. (2019). Genome-wide association study of statin-induced myopathy in patients recruited using the UK clinical practice research datalink. Clin Pharmacol Ther. http://doi.org/10.1002/cpt.1557